Brookline Capital Management Forecasts BIOX Q3 Earnings

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Investment analysts at Brookline Capital Management cut their Q3 2025 earnings per share (EPS) estimates for shares of Bioceres Crop Solutions in a research note issued on Thursday, February 13th. Brookline Capital Management analyst K. Dolliver now forecasts that the company will post earnings per share of ($0.05) for the quarter, down from their previous forecast of $0.02. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.12 per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions’ Q4 2025 earnings at $0.15 EPS, FY2025 earnings at $0.02 EPS, FY2027 earnings at $0.66 EPS, FY2028 earnings at $0.77 EPS and FY2029 earnings at $0.97 EPS.

Other equities analysts have also recently issued research reports about the company. Oppenheimer dropped their target price on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a report on Tuesday, January 28th. Lake Street Capital dropped their price objective on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating for the company in a report on Friday, February 7th. Finally, Canaccord Genuity Group dropped their price objective on Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating for the company in a report on Thursday, February 13th. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $9.88.

Bioceres Crop Solutions Price Performance

Shares of Bioceres Crop Solutions stock opened at $4.83 on Monday. The stock has a market cap of $302.89 million, a price-to-earnings ratio of 241.62 and a beta of 0.57. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27. The stock has a 50 day moving average price of $6.39 and a 200-day moving average price of $7.49. Bioceres Crop Solutions has a one year low of $4.42 and a one year high of $13.60.

Institutional Investors Weigh In On Bioceres Crop Solutions

Several hedge funds have recently made changes to their positions in the company. Maven Securities LTD purchased a new stake in shares of Bioceres Crop Solutions in the 4th quarter worth $152,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Bioceres Crop Solutions by 135.0% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 752,335 shares of the company’s stock worth $4,574,000 after buying an additional 432,206 shares during the period. Bank of America Corp DE lifted its holdings in shares of Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after buying an additional 3,735 shares during the period. Northern Trust Corp purchased a new stake in shares of Bioceres Crop Solutions in the 4th quarter worth $93,000. Finally, Long Focus Capital Management LLC lifted its stake in shares of Bioceres Crop Solutions by 130.7% during the 4th quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company’s stock worth $4,528,000 after purchasing an additional 421,931 shares during the last quarter. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.